According to a new report by Polaris Market Research, the global synthetic biology market was valued at USD 17.96 billion in 2025 and is projected to reach USD 73.62 billion by 2034, expanding at a CAGR of 16.97% over the forecast period. Growth is underpinned by rising adoption of precision medicine, expanding regenerative medicine research, and accelerating commercialization of engineered biological products across key end-use industries.

What Is Driving Synthetic Biology Market Growth?

Demand is climbing as precision medicine adoption converges with falling DNA synthesis costs and growing biomanufacturing investment. Biotechnology and pharmaceutical companies are prioritizing AI-assisted biological design, pushing synthetic biology adoption across therapeutic development and diagnostics. Polaris analysts note that Weill Cornell Medicine's February 2026 launch of a new laboratory to accelerate personalized cell-based cancer therapies positions the healthcare segment for sustained growth through 2034, with enzymes emerging as the largest product contributor and bioinformatics and computer-aided design platforms posting the fastest incremental gains.

Key Trends Shaping the Synthetic Biology Industry

AI-Accelerated Biological Discovery

Artificial intelligence is becoming foundational to biological design workflows. In April 2026, Biohub launched its Virtual Biology Initiative to build a foundational open dataset for AI-accelerated biology, aiming to reduce the number of laboratory experiments required and reflecting the industry trend toward computational-first discovery pipelines.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/synthetic-biology-market

Agricultural Biotechnology Expansion

Engineered crops are emerging as a significant growth vector. The European Union's 2023 Common Agricultural Policy allocates approximately USD 345 billion over five years to support sustainable farming, including incentives for carbon sequestration, reinforcing the regulatory landscape supporting engineered plants with higher yields and improved climate tolerance.

Global Biosecurity and Research Infrastructure Investment

Institutions are building dedicated capacity to manage the field's rapid growth. In June 2026, A*STAR SIFBI and the National University of Singapore launched a joint synthetic biology lab to advance innovation and commercialization, while Imperial College London launched a Biosecurity Network of Excellence the same month to address emerging biological threats shaped by AI and biotechnology.

Market Segmentation: Breaking Down the Synthetic Biology Market

Polaris segments the synthetic biology market by product, technology, application, end user, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Product

Enzymes dominated the market with a 31.40% revenue share in 2025, given their extensive use across genome editing, DNA assembly, and synthetic pathway engineering. Synthetic DNA and oligonucleotides are projected to grow at the fastest CAGR through 2034 as gene synthesis and genome editing demand accelerates across academic and commercial laboratories.

By Technology

PCR technology led the market in 2025, remaining widely used for validation, screening, diagnostics, and quality control. Bioinformatics and computer-aided design platforms are projected to register the fastest CAGR at 22.40%, driven by increasing adoption of machine learning tools for genetic circuit design and protein engineering.

By Application

Healthcare & pharmaceuticals dominated the market in 2025 on strong demand for biologics, gene therapies, and precision medicine applications. Food & agriculture is expected to grow at the fastest CAGR, supported by precision fermentation and sustainable food production initiatives.

By End User

Biotechnology and pharmaceutical companies held the largest share at 46.80% in 2025, reflecting substantial investment in biologics development and gene therapies. Industrial biotechnology companies are projected to grow fastest, driven by increasing commercialization of sustainable, bio-based manufacturing.

Regional Outlook: Where Is Synthetic Biology Growing Fastest?

North America held the largest share at 42.10% in 2025, supported by substantial biotechnology funding, advanced research institutions, and extensive venture capital activity. Asia Pacific is projected to grow at the fastest CAGR through 2034, driven by expanding biotechnology investments and supportive government policies — India alone added over 1,500 biotech startups in 2024, bringing its total to 10,075, backed by more than 95 DBT-BIRAC bio-incubators. Within North America, the U.S. remains the largest single market; within Asia Pacific, China, Japan, and India are becoming important innovation and manufacturing hubs, while Europe's strength lies in its industrial biotechnology and pharmaceutical manufacturing base led by Germany.

Competitive Landscape: Leading Synthetic Biology Companies

Key players profiled in the report include Thermo Fisher Scientific Inc., Danaher Corporation, GenScript Biotech Corporation, Twist Bioscience Corporation, Ginkgo Bioworks Holdings Inc., and Merck KGaA, who are focusing on AI-enabled discovery platforms, biomanufacturing facility investment, and research partnerships to strengthen market position across the enzymes and healthcare segments outlined above. Recent moves include Agilent Technologies' May 2026 announcement of a USD 50 million investment in its Massachusetts manufacturing plant, aimed at deepening life science and biopharmaceutical production capacity across North America.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching engineered biology sourcing, this report benchmarks synthetic biology market share, segment-level pricing, and forecast data — by product, technology, application, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing DNA synthesis and genome engineering vendors, investors sizing entry points in industrial biotechnology, and strategy teams tracking food & agriculture as a growth adjacency.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

bim-transforming-future-of-construction

e-learning-market

styrene-butadiene-rubber-latex-is-a-versatile-material-for-modern-manufacturing

chlorinated-polyvinyl-chloride-cpvc-market

edge-ai-market

medical-aesthetics-market

sunglasses-market

water-treatment-chemicals-market

aesthetic-exosomes-market